Janus Henderson Group PLC Intra Cellular Therapies, Inc. Put Options Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ITCI
# of Institutions
399Shares Held
88.4MCall Options Held
365KPut Options Held
306K-
Vanguard Group Inc Valley Forge, PA9.63MShares$849 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$558 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.29MShares$466 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.72MShares$328 Million1.37% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.05MShares$269 Million3.36% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $8.33B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...